Grunnleggende statistikk
| CIK | 1577916 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Premier, Inc.
SEC Filings (Chronological Order)
På denne siden finner du en fullstendig, kronologisk liste over SEC-arkiveringer, med unntak av eierskaps-arkiveringer som vi leverer andre steder.
| August 20, 2025 |
Premier, Inc. Fiscal 2025 Q4 Earnings Call Transcript August 19, 2025, 8:00 a.m. ET EX-99.2 Exhibit 99.2 Premier, Inc. Fiscal 2025 Q4 Earnings Call Transcript August 19, 2025, 8:00 a.m. ET CORPORATE PARTICIPANTS • Michael Alkire - Premier, Inc. - President, CEO & Director • Glenn Coleman - Premier, Inc. - Chief Administrative and Financial Officer • David Zito - Premier, Inc. - President, Performance Services • Ben Krasinski - Premier, Inc. - Senior Director, Investor Relations C |
|
| August 20, 2025 |
Fiscal-Year 2026 Guidance Range [1] [2] (as of August 19, 2025) EX-99.1 Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2025 Fourth-Quarter and Full-Year Financial Results • Fourth-quarter total net revenue of $262.9 million was better than the company expected (total net revenue excluding Contigo Health* of $258.0 million) • Fourth-quarter GAAP net income from continuing operations of $18.0 million, or $0.22 per fully diluted share • Fourth-quarter adjusted EP |
|
| August 20, 2025 |
EX-99.3 Fiscal 2025 Fourth-Quarter Earnings Conference Call August 19, 2025 Exhibit 99.3 Forward-Looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and accompanying webcast that are not statements of historical or current facts, including, but not limited to, those related to our ability to advance our business strategies and improv |
|
| August 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 17, 2025 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 19, 2025 |
Insider Trading Policy of the Company Exhibit 19.1 Insider Trading Policy 1. Purpose To promote compliance with applicable securities laws by Premier, Inc., Premier Healthcare Solutions, Inc., Premier Healthcare Alliance, L.P. and their respective subsidiaries (“Premier” or the “Company”) and all directors, officers and employees thereof, in order to preserve the reputation and integrity of Premier as well as that of persons affiliate |
|
| August 19, 2025 |
Dodd-Frank Compensation Recoupment Policy of the Company* Exhibit 97 DODD-FRANK COMPENSATION RECOUPMENT POLICY The Board of Directors of Premier, Inc. |
|
| August 19, 2025 |
Exhibit 21 SUBSIDIARIES OF PREMIER, INC. As of August 19, 2025 Name of Subsidiary State/Province of Incorporation Premier Healthcare Solutions, Inc. (1) Delaware Premier Services II, LLC (2) Delaware Premier Healthcare Alliance, L.P. (3) California Premier Marketplace, LLC (4) Delaware Premier Supply Chain Holdings, LLC (4) Delaware Premier Supply Chain Improvement, LLC (4) Delaware Care to Care I |
|
| August 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premier, Inc. (Exa |
|
| August 19, 2025 |
Rule 10b5-1 Plan Policy of the Company* Exhibit 19.2 Rule 10b5-1 Plan Policy 1.Purpose To be read in conjunction with the Company’s Insider Trading Policy (the “Insider Trading Policy”). Terms used in this Rule 10b5-1 Plan Policy and not otherwise defined have the meanings set forth in the Insider Trading Policy. Unless the context otherwise requires, references to the “Company” in this Policy refer to the Company, Premier Healthcare So |
|
| August 19, 2025 |
Third Amendment to Premier Healthcare Solutions, Inc. Deferred Compensation Plan dated November Exhibit 10.33 THIRD AMENDMENT TO THE PREMIER HEALTHCARE SOLUTIONS, INC. DEFERRED COMPENSATION PLAN WHEREAS, Premier Healthcare Solutions, Inc. (the “Company”) maintains the Premier Healthcare Solutions, Inc. Deferred Compensation Plan (the “Plan”) for the benefit of select employees; WHEREAS, amendment of the Plan is now considered desirable to allow the Plan to recognize a qualified domestic rela |
|
| July 7, 2025 |
EX-99.1 Exhibit 99.1 Premier, Inc. Stewardship Outreach July 2025 Forward-looking statements Forward-looking statements – Statements made in this presentation that are not statements of historical or current facts, such as those related to our ability to advance our business strategies and improve healthcare, the intended or expected performance or utility of our products and services, our ability |
|
| July 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 7, 2025 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction (Commission (I.R.S. Employer of incorporat |
|
| May 7, 2025 |
Fiscal-Year 2025 Guidance Range [1] [2] (as of May 6, 2025) EX-99.1 Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2025 Third-Quarter Financial Results • Total net revenue of $261.4 million (total net revenue excluding Contigo Health* of $255.3 million) • GAAP net income from continuing operations of $27.6 million, or $0.32 per fully diluted share • Adjusted earnings per share excluding Contigo Health* of $0.46 • Net cash provided by operating activities f |
|
| May 7, 2025 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 6, 2025 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 7, 2025 |
Premier, Inc. Fiscal 2025 Q3 Earnings Call Transcript May 6, 2025, 8:00 a.m. ET Exhibit 99.2 Premier, Inc. Fiscal 2025 Q3 Earnings Call Transcript May 6, 2025, 8:00 a.m. ET CORPORATE PARTICIPANTS • Michael Alkire - Premier, Inc. - President, CEO & Director • Glenn Coleman - Premier, Inc. - Chief Administrative and Financial Officer • Ben Krasinski - Premier, Inc. - Senior Director, Investor Relations CONFERENCE CALL PARTICIPANTS • Kevin Caliendo - UBS - Analyst • Eric Percher |
|
| May 7, 2025 |
Exhibit 99.3 Fiscal 2025 Third-Quarter Earnings Conference Call May 6, 2025 © 2025. ALL RIGHTS RESERVED. | PREMIER INC. | 1 Forward-Looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to our ability to advance our business strat |
|
| May 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premier, |
|
| February 19, 2025 |
Exhibit 10.2 EXECUTION VERSION February 18, 2025 To: Premier, Inc. 13034 Ballantyne Corporate Place Charlotte, NC 28277 Attn: Glenn Coleman, Chief Administrative and Financial Officer Email: [email protected] From: JPMorgan Chase Bank, National Association New York Branch 383 Madison Avenue New York, NY, 10179 Re: Issuer Forward Repurchase Transaction – Tranche 2 Ladies and Gentlemen: Th |
|
| February 19, 2025 |
Exhibit 10.1 EXECUTION VERSION February 18, 2025 To: Premier, Inc. 13034 Ballantyne Corporate Place Charlotte, NC 28277 Attn: Glenn Coleman, Chief Administrative and Financial Officer Email: [email protected] From: JPMorgan Chase Bank, National Association New York Branch 383 Madison Avenue New York, NY, 10179 Re: Issuer Forward Repurchase Transaction – Tranche 1 Ladies and Gentlemen: Th |
|
| February 19, 2025 |
Premier, Inc. Enters Into $200 Million Accelerated Share Repurchase Program Exhibit 99.1 Premier, Inc. Enters Into $200 Million Accelerated Share Repurchase Program CHARLOTTE, N.C., February 18, 2025 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that it has entered into accelerated share repurchase agreements with JPMorgan Chase Bank, National Association (“JPMorgan”) to repurchase an aggregate of $200 million |
|
| February 19, 2025 |
Regulation FD Disclosure, Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 14, 2025 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| February 5, 2025 |
Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2025 Second-Quarter Results • Total net revenue of $240.3 million (Total net revenue excluding Contigo Health* of $232.2 million) • GAAP net loss from continuing operations of $45.8 million, or $(0.60) per fully diluted share, which includes a $126.8 million impairment charge to goodwill related to the company’s data and technology business in the Per |
|
| February 5, 2025 |
Fiscal 2025 Second-Quarter Earnings Conference Call February 4, 2025 Exhibit 99.3 Fiscal 2025 Second-Quarter Earnings Conference Call February 4, 2025 Forward-Looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to our ability to advance our business strategies and improve healthcare, our ability |
|
| February 5, 2025 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 4, 2025 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| February 5, 2025 |
Premier, Inc. Fiscal 2025 Q2 Earnings Call Transcript February 4, 2025, 8:00 a.m. ET Exhibit 99.2 Premier, Inc. Fiscal 2025 Q2 Earnings Call Transcript February 4, 2025, 8:00 a.m. ET CORPORATE PARTICIPANTS • Michael Alkire Premier, Inc. - President, CEO & Director • Ben Krasinski Premier, Inc. - Senior Director, Investor Relations • Glenn Coleman Premier, Inc. - Chief Administrative and Financial Officer CONFERENCE CALL PARTICIPANTS • Michael Cherny Leerink Partners - Analyst • Er |
|
| February 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premie |
|
| February 4, 2025 |
Executive Employment and Restrictive Covenant Agreement dated Exhibit 10.1 EXECUTIVE EMPLOYMENT AND RESTRICTIVE COVENANT AGREEMENT I, David Zito, hereby agree to be employed by Premier Healthcare Solutions, Inc. (the “Company”) and, subject to approval of the Board of Directors of Premier, Inc. (the “Board”) and all necessary committees of the Board, the Company hereby agrees to employ me, subject to the following terms and conditions (the “Agreement”). If f |
|
| February 4, 2025 |
Exhibit 10.5 Directors’ Compensation Policy Overview The Board of Directors of Premier, Inc. (“Premier”) has approved the following Director Compensation Policy (“Policy”) to provide an incentive to attract and retain the services of qualified persons to serve as directors. Objectives This Policy is designed to achieve the following key objectives: •Align the interests of the non-employee director |
|
| February 4, 2025 |
Directors under the Premier, Inc. 2023 Equity Incentive Plan (for December 2024 and later awar Exhibit 10.4 RESTRICTED STOCK UNIT AGREEMENT FOR NON-EMPLOYEE DIRECTORS Participant: #ParticipantName# Grant Date: #GrantDate# (the “Grant Date”) Number of Award Shares: #QuantityGranted# Vesting Date: Shall vest in full on the first anniversary of the Grant Date (the “Vesting Date”). 1.Grant of Restricted Stock Units. This restricted stock unit award (“Award”) is granted pursuant to the Premier I |
|
| February 4, 2025 |
, between Premier Healthcare Solutions, Inc. and Exhibit 10.2 Confidential - Signing Bonus Agreement Prepared for: David Zito Prepared date: December 2, 2024 Signing Bonus Amount: $400,000.00 In consideration of your employment with Premier Healthcare Solutions, Inc. (“Premier” or the “Company”), the Company agrees to pay you a signing bonus in the gross amount of $400,000.00 (the “Signing Bonus”), subject to your agreement to the terms and cond |
|
| January 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 14, 2025 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 14, 2025 |
Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 14, 2025 Exhibit 99.2 Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 14, 2025 CHARLOTTE, NC, Jan. 7, 2025 – Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025. The company’s formal presentation will begin |
|
| January 14, 2025 |
43rd Annual J.P. Morgan Healthcare Conference Exhibit 99.1 43rd Annual J.P. Morgan Healthcare Conference January 14, 2025 Presented by: Michael J. Alkire Glenn Coleman President and CEO Chief Administrative and Financial Officer Forward-looking Statements Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to our ability to |
|
| December 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 6, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| December 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 2, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| December 3, 2024 |
Premier, Inc. Appoints David Zito as President, Performance Services Exhibit 99.1 Premier, Inc. Appoints David Zito as President, Performance Services CHARLOTTE, N.C. – December 3, 2024 – Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that it has named David (Dave) Zito as President, Performance Services, effective December 6, 2024. Zito will oversee Premier’s Performance Services segment, including the con |
|
| December 3, 2024 |
Exhibit 10.1 Execution Version MASTER CONSULTING SERVICES AGREEMENT This Master Consulting Services Agreement (the “Agreement”) is entered into as of the 2nd day of December 2024 by and between Premier Healthcare Solutions, Inc. (“Premier”) and Leigh Anderson (“Consultant”), (hereinafter collectively referred to as the “Parties” and each individually a “Party”). WHEREAS, the Parties wish to enter |
|
| November 6, 2024 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 5, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 6, 2024 |
Fiscal 2025 First-Quarter Earnings Conference Call /////// November 5, 2024 Exhibit 99. |
|
| November 6, 2024 |
Exhibit 99.2 CORPORATE PARTICIPANTS • Michael Alkire Premier, Inc. - President, CEO & Director • Ben Krasinski Premier, Inc. - Senior Director, Investor Relations • Craig McKasson Premier, Inc. - Chief Administrative and Financial Officer & SVP CONFERENCE CALL PARTICIPANTS • Eric Percher Nephron Research LLC - Analyst • Michael Cherny Leerink Partners LLC - Analyst • Jessica Tassan Piper Sandler & |
|
| November 6, 2024 |
Premier, Inc. Reports Fiscal-Year 2025 First-Quarter Results Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2025 First-Quarter Results CHARLOTTE, N.C., November 5, 2024 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 first quarter ended September 30, 2024. On October 1, 2024, the company announced that it had divested the S2S Global direct sourcing business |
|
| November 5, 2024 |
Exhibit 10.2 RESTRICTED STOCK UNIT AGREEMENT Participant: [Participant Name] Grant Date: [Grant Date] (the “Grant Date”) Number of Award Shares: [Number of Award Shares Granted] Vesting Schedule: 1/3rd of Award Shares vest on each of the first, second and third anniversaries of Grant Date This Restricted Stock Unit Agreement (the “Award Agreement”) evidences the grant to the Participant by Premier |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premi |
|
| November 5, 2024 |
Premier, Inc. Annual Incentive Compensation Plan, amended and restated effective September Exhibit 10.3 PREMIER, INC. ANNUAL INCENTIVE COMPENSATION PLAN AMENDED AND RESTATED ON September 6, 2024 Effective for Plan Years Beginning On or After July 1, 2024 ARTICLE 1. PLAN AMENDMENT AND RESTATEMENT; PURPOSE 1.1Amendment and Restatement. Premier, Inc., a Delaware corporation (the “Company”), hereby amends and restates its annual incentive compensation plan, which is known as the Premier, In |
|
| November 5, 2024 |
Exhibit 10.1 PERFORMANCE SHARE AWARD AGREEMENT Participant: [Participant Name] Grant Date: [Grant Date] (the “Grant Date”) Target Number of Performance Shares: [Target Number of Performance Shares Granted] Performance Cycle: July 1, 20 - June 30, 20 Vesting Schedule: Shares vest after the Performance Cycle based on performance against goals This Performance Share Award Agreement (the “Award Agreem |
|
| November 5, 2024 |
Exhibit 10.4 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of September 23, 2024, is by and among PREMIER HEALTHCARE ALLIANCE, L.P., a California limited partnership, PREMIER SUPPLY CHAIN IMPROVEMENT, INC., a Delaware corporation (“PSCI”) and PREMIER HEALTHCARE SOLUTIONS, INC., a Delaware corporation (each individuall |
|
| October 31, 2024 |
PINC / Premier, Inc. / DIMENSIONAL FUND ADVISORS LP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Premier Inc (Name of Issuer) Common Stock (Title of Class of Securities) 74051N102 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is |
|
| October 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 21, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| October 21, 2024 |
Exhibit 99.1 2024 Sustainability Report Forward-Looking Statements Statements made in this report that are not statements of historical or current facts, such as those related to Premier's ability to advance its growth strategies and develop innovations for, transform and improve healthcare, the intended or expected performance or utility of Premier's products and services, and Premier's ability t |
|
| October 21, 2024 |
2024NoticeofAnnualMeeting andProxyStatementOctober21,2024 DearPremierStockholders: I am pleased to invite you to attend the Premier, Inc. |
|
| October 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| August 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premier, Inc. (Exa |
|
| August 21, 2024 |
EX-99.2 Exhibit 99.2 August 20, 2024 / 8:00 AM ET - Premier, Inc. Q4 2024 Earnings Call CORPORATE PARTICIPANTS • Michael Alkire Premier, Inc. - President, CEO & Director • Ben Krasinski Premier, Inc. - Senior Director, Investor Relations • Craig McKasson Premier, Inc. - Chief Administrative and Financial Officer & SVP CONFERENCE CALL PARTICIPANTS • Operator • Eric Percher Nephron Research LLC - An |
|
| August 21, 2024 |
Exhibit 19.2 Rule 10b5-1 Plan Policy 1.Purpose To be read in conjunction with the Company’s Insider Trading Policy (the “Insider Trading Policy”). Terms used in this Rule 10b5-1 Plan Policy and not otherwise defined have the meanings set forth in the Insider Trading Policy. Unless the context otherwise requires, references to the “Company” in this Policy refer to the Company, Premier Healthcare So |
|
| August 21, 2024 |
Exhibit 19.1 Insider Trading Policy 1. Purpose To promote compliance with applicable securities laws by Premier, Inc., Premier Healthcare Solutions, Inc., Premier Healthcare Alliance, L.P. and their respective subsidiaries (“Premier” or the “Company”) and all directors, officers and employees thereof, in order to preserve the reputation and integrity of Premier as well as that of persons affiliate |
|
| August 21, 2024 |
EX-99.3 Fiscal 2024 Fourth-Quarter Earnings Conference Call /////// August 20, 2024 Exhibit 99.3 Forward-looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to our ability to advance our long-term strategies and develop innovati |
|
| August 21, 2024 |
Exhibit 21 SUBSIDIARIES OF PREMIER, INC. As of August 20, 2024 Name of Subsidiary State/Province of Incorporation Premier Healthcare Solutions, Inc. (1) Delaware Premier Services II, LLC (2) Delaware Premier Healthcare Alliance, L.P. (3) California Premier Marketplace, LLC (4) Delaware Premier Supply Chain Holdings, LLC (4) Delaware Premier Supply Chain Improvement, Inc. (4) Delaware Care to Care |
|
| August 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 20, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 21, 2024 |
Premier, Inc. Reports Fiscal-Year 2024 Fourth-Quarter and Full-Year Results EX-99.1 Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2024 Fourth-Quarter and Full-Year Results CHARLOTTE, N.C., August 20, 2024 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 fourth quarter and full year ended June 30, 2024. “I would like to thank our employees for another year of dedication to |
|
| August 21, 2024 |
Exhibit 97 DODD-FRANK COMPENSATION RECOUPMENT POLICY The Board of Directors of Premier, Inc. |
|
| August 20, 2024 |
Exhibit 99.1 Premier, Inc. Appoints Glenn Coleman as Chief Administrative and Financial Officer Craig McKasson to Retire at the End of December 2024 CHARLOTTE, N.C. – August 20, 2024 – Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that Glenn Coleman, CPA, was unanimously appointed by the Board of Directors to serve as the Chief Administra |
|
| August 20, 2024 |
Exhibit 10.4 Confidential—Signing Bonus Agreement Prepared for: Glenn Coleman Prepared date: August 15, 2024 Signing Bonus Amount: $800,000 (payable in two equal payments) In consideration of your employment with Premier Healthcare Solutions, Inc. (“Premier” or the “Company”), the Company agrees to pay you a signing bonus in the gross amount of $800,000 (the “Signing Bonus”), subject to your agree |
|
| August 20, 2024 |
Exhibit 10.2 MASTER CONSULTING SERVICES AGREEMENT This Master Consulting Services Agreement (the “Agreement”) is entered into as of the 15th day of August 2024 by and between Premier Healthcare Solutions, Inc. (“Premier”) and Craig McKasson (“Consultant”), (hereinafter collectively referred to as the “Parties” and each individually a “Party”). WHEREAS, the Parties wish to enter into an agreement w |
|
| August 20, 2024 |
Exhibit 10.1 FIRST AMENDMENT TO SENIOR EXECUTIVE EMPLOYMENT AGREEMENT This First Amendment to Senior Executive Employment Agreement (the “Amendment”) is entered into effective as of November 11, 2024 (the “Amendment Effective Date”) by and between Premier Healthcare Solutions, Inc. (“Premier” or the “Company”) and Craig McKasson (“Executive”). Premier and Executive shall be referred to herein some |
|
| August 20, 2024 |
Exhibit 10.3 EXECUTIVE EMPLOYMENT AND RESTRICTIVE COVENANT AGREEMENT I, Glenn Coleman hereby agree to be employed by Premier Healthcare Solutions, Inc. (the “Company”) and, subject to approval of the Board of Directors of Premier, Inc. (the “Board”) and all necessary committees of the Board, the Company hereby agrees to employ me, subject to the following terms and conditions (the “Agreement”). If |
|
| August 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 15, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 7, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| July 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 12, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Number |
|
| July 12, 2024 |
Stewardship Outreach July 2024 Exhibit 99.1 Forward-looking statements Forward-looking statements – Statements made in this presentation that are not statements of historical or current facts, such as those related to our ability to advance our growth strategies and develop innovations for, transform and improve healthcare, our financial position and capital deployment strategies, our ability to f |
|
| May 8, 2024 |
Exhibit 99.2 May 7, 2024 / 8:00AM – PINC Q3 2024 Premier, Inc. Earnings Call CORPORATE PARTICIPANTS Ben Krasinski Premier, Inc. - Senior Director of IR Craig Steven McKasson Premier, Inc. - Chief Administrative & Financial Officer & SVP Leigh T. Anderson Premier, Inc. - Chief Operating Officer Michael J. Alkire Premier, Inc. - President, CEO & Director PRESENTATION Operator Good morning, and welco |
|
| May 8, 2024 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 7, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 8, 2024 |
Premier, Inc. Reports Fiscal-Year 2024 Third-Quarter Results Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2024 Third-Quarter Results • Reaffirming fiscal 2024 financial guidance ranges • Executed $400 million accelerated share repurchase transaction CHARLOTTE, N.C., May 7, 2024 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 third quarter ended March 31, |
|
| May 8, 2024 |
Fiscal 2024 Third-Quarter Earnings Conference Call /////// May 7, 2024 Exhibit 99. |
|
| May 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premier, |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 16, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| April 16, 2024 |
NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF DERIVATIVE ACTION EX-99.2 Exhibit 99.2 IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE CITY OF WARREN GENERAL EMPLOYEES’ RETIREMENT SYSTEM, ) ) ) ) Plaintiff, ) ) v. ) C.A. No. 2022-0207-JTL ) MICHAEL ALKIRE, et al., ) ) Defendants, ) ) and ) ) PREMIER, INC., ) ) Nominal Defendant. ) NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF DERIVATIVE ACTION TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF COMMON STOCK OF PRE |
|
| April 16, 2024 |
EX-99.1 Exhibit 99.1 EFiled: Feb 16 2024 05:00PM EST Transaction ID 72069458 Case No. 2022-0207-JTL IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE CITY OF WARREN GENERAL ) EMPLOYEES’ RETIREMENT ) SYSTEM, ) ) Plaintiff, ) ) v. ) C.A. No. 2022-0207-JTL ) MICHAEL ALKIRE, et al., ) ) Defendants, ) ) and ) ) PREMIER, INC., ) ) Nominal Defendant. ) STIPULATION AND AGREEMENT OF COMPROMISE, SETTLEMENT |
|
| February 13, 2024 |
PINC / Premier, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01730-premierincclassa.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Premier, Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 74051N102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to desig |
|
| February 7, 2024 |
Premier, Inc. Completes Strategic Review Process Exhibit 99.2 Premier, Inc. Completes Strategic Review Process • Board Authorizes $1.0 Billion Share Repurchase Authorization, Including $400 Million Accelerated Share Repurchase (ASR) Transaction • Company Will Seek Partners to Take Ownership of Some or All of Premier’s Holdings in Contigo Health and S2S Global CHARLOTTE, N.C. – February 5, 2024 – Premier, Inc. (NASDAQ: PINC) (“Premier” or the “Co |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 5, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| February 7, 2024 |
Premier, Inc. Reports Fiscal-Year 2024 Second-Quarter Results Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2024 Second-Quarter Results CHARLOTTE, N.C., February 5, 2024 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2024 second quarter ended December 31, 2023. “Our second quarter results reflect ongoing discipline in actively managing our business to meet our |
|
| February 7, 2024 |
Fiscal 2024 Second-Quarter Earnings Conference Call /////// February 6, 2024 Exhibit 99. |
|
| February 7, 2024 |
Exhibit 99.3 February 6, 2024 / 8:00AM - PINC Q2 2024 Premier, Inc. Earnings Call CORPORATE PARTICIPANTS Ben Krasinski Premier, Inc. – Senior Director of IR Craig S. McKasson Premier, Inc. – Chief Administrative & Financial Officer & SVP Michael J. Alkire Premier, Inc. – President, CEO & Director PRESENTATION Operator Good morning, and welcome to Premier’s Fiscal 2024 Second Quarter Conference Cal |
|
| February 7, 2024 |
Exhibit 10.1 Execution Version February 5, 2024 To: Premier, Inc. 13034 Ballantyne Corporate Place Charlotte, NC 28277 Attn: Craig McKasson, Chief Administrative and Financial Officer Email: [email protected] From: Bank of America, N.A. Bank of America Tower at One Bryant Park New York, New York 10036 Attention: Strategic Equity Solutions Group Telephone: 646-855-8900 Email: dg.iss |
|
| February 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premie |
|
| February 6, 2024 |
RESTRICTED STOCK UNIT AGREEMENT FOR NON-EMPLOYEE DIRECTORS Participant: #Participant Name# Grant Date: #Grant Date# (the “Grant Date”) Number of Award Shares: #Quantity Granted# Vesting Date: Shall vest in full on the first anniversary of the Grant Date (the “Vesting Date”). |
|
| January 26, 2024 |
Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF PREMIER, INC. ARTICLE I STOCKHOLDERS Section 1. The annual meeting of the stockholders of Premier, Inc. (the “Corporation”) for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on such date, and at such time and place, if any, within or without the State of Delawar |
|
| January 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 25, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 9, 2024 |
42nd Annual J.P. Morgan Healthcare Conference Michael J. Alkire, President and CEO Craig McKasson, Chief Administrative and Financial Officer January 9, 2024 Exhibit 99.1 Forward-Looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those relat |
|
| January 9, 2024 |
Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 9, 2024 Exhibit 99.2 Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 9, 2024 CHARLOTTE, NC, Jan. 4, 2024 – Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 9, 2024. The company’s formal presentation will begin a |
|
| January 9, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 9, 2024 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 4, 2023 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 1, 2023 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| December 4, 2023 |
Exhibit 10.1 PREMIER, INC. 2023 EQUITY INCENTIVE PLAN (effective December 1, 2023) 1. Establishment, Purpose and Duration. Premier, Inc. (referred to below as the “Company”) establishes the Premier, Inc. 2023 Equity Incentive Plan, effective upon approval by the Company’s stockholders on December 1, 2023 as a successor to the Company’s 2013 Equity Incentive Plan as amended and restated (hereinafte |
|
| December 1, 2023 |
As filed with the Securities and Exchange Commission on December 1, 2023. As filed with the Securities and Exchange Commission on December 1, 2023. Registration No. 333- UNITES STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PREMIER, INC. (Exact name of registrant as specified in its charter) Delaware 35-2477140 (State or other jurisdiction of incorporation or organization) (IRS Employer I |
|
| December 1, 2023 |
Exhibit 107 CALCUATION OF FILING FEE TABLE Form S-8 (Form Type) Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit(2) Maximum Aggregate Offering Price(2) Fee Rate Amount of Registration Fee Equity Class A Common Stock, par valu |
|
| December 1, 2023 |
(Incorporated by reference to Exhibit 99.1 to our Current Repo Exhibit 99.1 PREMIER, INC. 2023 EQUITY INCENTIVE PLAN (effective December 1, 2023) 1. Establishment, Purpose and Duration. Premier, Inc. (referred to below as the “Company”) establishes the Premier, Inc. 2023 Equity Incentive Plan, effective upon approval by the Company’s stockholders on December 1, 2023 as a successor to the Company’s 2013 Equity Incentive Plan as amended and restated (hereinafte |
|
| November 8, 2023 |
NOVEMBER 07, 2023 / 8:00AM – PINC Q1 2024 Premier, Inc. Earnings Call Exhibit 99.2 NOVEMBER 07, 2023 / 8:00AM – PINC Q1 2024 Premier, Inc. Earnings Call CORPORATE PARTICIPANTS Ben Krasinski Premier, Inc. – Senior Director of IR Craig S. McKasson Premier, Inc. – Chief Administrative & Financial Officer & SVP Michael J. Alkire Premier, Inc. – President, CEO & Director PRESENTATION Operator Good morning, and welcome to Premier’s Fiscal 2024 First Quarter Conference Cal |
|
| November 8, 2023 |
Regulation FD Disclosure, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 7, 2023 Premier, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 8, 2023 |
Fiscal 2024 First-Quarter Earnings Conference Call /////// November 7, 2023 Exhibit 99. |
|
| November 8, 2023 |
Premier, Inc. Reports Fiscal-Year 2024 First-Quarter Results Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2024 First-Quarter Results CHARLOTTE, N.C., November 7, 2023 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2024 first quarter ended September 30, 2023. “Our first quarter results reflect continued progress in advancing our strategy to technology-enable b |
|
| November 7, 2023 |
and Premier Healthcare Solutions, Inc.+* EXHIBIT 10.2 EXECUTIVE EMPLOYMENT AND RESTRICTIVE COVENANT AGREEMENT I, Crystal Climer, hereby agree to be employed by Premier Healthcare Solutions, Inc. (the “Company”) and the Company hereby agrees to employ me, subject to the following terms and conditions (the “Agreement”). 1.EMPLOYMENT 1.1Job Duties. I agree to devote my full professional time, attention and best efforts to the performance of |
|
| November 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premi |
|
| November 7, 2023 |
, by and between Andy Brailo and Premier Healthcare Solutions, Inc. Exhibit 10.1 Confidential EXECUTIVE EMPLOYMENT AGREEMENT I, Andy Brailo, hereby agree to be employed by Premier Healthcare Solutions, Inc., a Delaware corporation with its principal places of business in Charlotte, North Carolina, Washington, D.C., and Ft. Lauderdale, Florida (“Premier” or the “Company”), and Premier hereby agrees to employ me, subject to the following terms and conditions. WHEREA |
|
| October 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 18, 2023 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 18, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| October 18, 2023 |
Exhibit 99.1 2023 TABLE OF CONTENTS LETTER FROM OUR PRESIDENT AND CEO 3 00 OVERVIEW 4 ABOUT US 5 OUR APPROACH TO SUSTAINABILITY 6 ABOUT THIS REPORT 8 ESG HIGHLIGHTS 9 AWARDS AND RECOGNITION 10 01 IMPROVING COMMUNITY HEALTH 11 IMPROVING PATIENT OUTCOMES AND LOWERING COSTS 12 SUPPORTING THE HEALTH OF HISTORICALLY MARGINALIZED PATIENTS 13 IMPROVING HEALTH THROUGH COMMUNITY DEVELOPMENT 14 02 ETHICS AN |
|
| October 18, 2023 |
2023NoticeofAnnualMeeting andProxyStatementOctober18,2023 DearPremierStockholders: I am pleased to invite you to attend the Premier, Inc. |
|
| September 19, 2023 |
PINC / Premier Inc - Class A / MILLENNIUM MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 PREMIER, INC. (Name of Issuer) CLASS A COMMON STOCK, PAR VALUE $0.01 PER SHARE (Title of Class of Securities) 74051N102 (CUSIP Number) SEPTEMBER 14, 2023 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to whi |
|
| September 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File N |
|
| September 12, 2023 |
Exhibit 99.1 Premier, Inc. Realigns Leadership Team and Promotes Key Executives to Accelerate Innovation and Profitable Growth • Leigh Anderson is now Chief Operating Officer • Andy Brailo is now Chief Commercial Officer • Bruce Radcliff is now Senior Vice President of Supply Chain Charlotte, N.C. – September 12, 2023 – Premier, Inc. (NASDAQ: PINC) (“Premier” or the “Company”), a leading technolog |
|
| August 23, 2023 |
Exhibit 21 SUBSIDIARIES OF PREMIER, INC. As of August 22, 2023 Name of Subsidiary State/Province of Incorporation Premier Healthcare Solutions, Inc. (1) Delaware Premier Services II, LLC (2) Delaware Premier Healthcare Alliance, L.P. (3) California Premier Marketplace, LLC (4) Delaware Premier Supply Chain Holdings, LLC (4) Delaware Premier Supply Chain Improvement, Inc. (4) Delaware Care to Care |
|
| August 23, 2023 |
RESTRICTED STOCK UNIT AGREEMENT Participant: [ Participant Name] Grant Date: [Grant Date] Number of Award Shares: [Number of Awards Granted] Vesting Schedule: 1/3rd of Award Shares vest on each of the first, second and third anniversaries of Grant Date This Restricted Stock Unit Agreement (the “Award Agreement”) evidences the grant to the Participant by Premier, Inc. |
|
| August 23, 2023 |
Fiscal 2023 Fourth-Quarter and Full-Year Earnings Conference Call /////// August 22, 2023 Exhibit 99. |
|
| August 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OF 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36092 Premier, Inc. (Exa |
|
| August 23, 2023 |
AUGUST 22, 2023 / 12:00PM, PINC.OQ - Q4 2023 Premier Inc Earnings Call Exhibit 99.2 AUGUST 22, 2023 / 12:00PM, PINC.OQ - Q4 2023 Premier Inc Earnings Call C O R P O R A T E P A R T I C I P A N T S Ben Krasinski Premier, Inc. - Senior Director, Investor Relations Craig Steven McKasson Premier, Inc. - Chief Administrative Officer, CFO, Senior VP & Treasurer Leigh T. Anderson Premier, Inc. - President of Performance Services Michael J. Alkire Premier, Inc. - President, |
|
| August 23, 2023 |
Premier, Inc. Reports Fiscal-Year 2023 Fourth-Quarter and Full-Year Results Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2023 Fourth-Quarter and Full-Year Results CHARLOTTE, N.C., August 22, 2023 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2023 fourth quarter and full year ended June 30, 2023. “I would like to express my gratitude to our employees for their hard work and |
|
| August 23, 2023 |
Amended and Restated Bylaws of Premier, Inc., effective as of AMENDED AND RESTATED BYLAWS OF PREMIER, INC. ARTICLE I STOCKHOLDERS Section 1. The annual meeting of the stockholders of Premier, Inc. (the "Corporation") for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on such date, and at such time and place, if any, within or without the State of Delaware as may be |
|
| August 23, 2023 |
SPECIAL RETENTION RESTRICTED STOCK UNIT AGREEMENT Participant: [ Participant Name] Grant Date: [Grant Date] Number of Award Shares: [Number of Awards Granted] Vesting Dates: 1/3rd of Award Shares vest on each of the first, second and third anniversaries of Grant Date This Special Retention Restricted Stock Unit Agreement (the “Award Agreement”) evidences the grant to the Participant by Premier, Inc. |
|
| August 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| July 25, 2023 |
Stewardship Outreach /////// July 2023 Exhibit 99.1 Forward-looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, including but not limited to those related to our ability to advance our long-term strategies, our ability to achieve annual and multi-yea |
|
| July 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Number |
|
| July 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Number |
|
| June 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Number |
|
| June 15, 2023 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Premier, Inc. to Divest Non-Healthcare GPO Operations for Approximately $800 Million in Cash Enables Company to Focus on Driving Growth in Core Healthcare Businesses Unlocks Significant Stockholder Value as Part of Ongoing Evaluation of Strategic Alternatives Charlotte, N.C. – June 14, 2023 – Premier, Inc. (NASDAQ: PINC) (“Premier” or the “Company”), a leading te |
|
| June 15, 2023 |
Exhibit 10.1 EXECUTION VERSION EQUITY PURCHASE AGREEMENT DATED AS OF JUNE 14, 2023 BY AND AMONG OMNIA PARTNERS, LLC, NON-HEALTHCARE HOLDINGS LLC, PREMIER HEALTHCARE ALLIANCE, L.P., ACURITY, LLC, INNOVATIX, LLC, ESSENSA VENTURES, LLC, PREMIER SUPPLY CHAIN IMPROVEMENT, INC., PREMIER HEALTHCARE SOLUTIONS, INC. AND PREMIER, INC. TABLE OF CONTENTS ARTICLE I. EQUITY INTEREST PURCHASE 2 Section 1.1 Sale |
|
| May 9, 2023 |
Premier, Inc. Evaluating Strategic Alternatives Exhibit 99.1 Premier, Inc. Evaluating Strategic Alternatives CHARLOTTE, N.C. – May 8, 2023 – Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors is evaluating potential strategic alternatives to enhance value for stockholders. The Board has established an Independent Special Committee composed of independent director |
|
| May 9, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 3, 2023 |
Premier, Inc. Reports Fiscal-Year 2023 Third-Quarter Results Updates Fiscal-Year 2023 Guidance Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2023 Third-Quarter Results Updates Fiscal-Year 2023 Guidance CHARLOTTE, N.C., May 2, 2023 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2023 third quarter ended March 31, 2023 and provided updates to its fiscal 2023 guidance. “We continue to make progres |
|
| May 3, 2023 |
EX-99.2 Exhibit 99.2 PREMIER PARTICIPANTS: Michael J. Alkire, President & CEO Craig McKasson, Chief Financial & Administrative Officer Angie McCabe, Vice President, Investor Relations OPERATOR: Good morning and welcome to Premier’s Fiscal 2023 Third Quarter Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an o |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36092 Premier, I |
|
| May 3, 2023 |
EX-99.3 Fiscal 2023 Third-Quarter Earnings Conference Call /////// May 2, 2023 Exhibit 99.3 Forward-looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to our ability to advance our long-term strategies, our ability to achieve f |
|
| March 7, 2023 |
Exhibit 21 SUBSIDIARIES OF PREMIER, INC. As of August 16, 2022 Name of Subsidiary State/Province of Incorporation Premier Healthcare Solutions, Inc. (1) Delaware Premier Services II, LLC (2) Delaware Premier Healthcare Alliance, L.P. (3) California Premier Supply Chain Improvement, Inc. (4) Delaware Premier Marketplace, LLC (4) Delaware Premier Supply Chain Holdings, LLC (4) Delaware NS3Health, LL |
|
| March 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Fiscal Year Ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OF 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission File Number 001-36092 Premier, I |
|
| March 6, 2023 |
CORRESP mwe.com March 7, 2023 VIA EDGAR AND EMAIL U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Stephen Kim Abe Friedman Re: Premier, Inc. Form 10-K for Fiscal Year Ended June 30, 2022 Filed August 16, 2022 File No. 001-36092 Dear Mr. Kim: On behalf of Premier, Inc., a Delaware corporation (the “Company”), we are respon |
|
| February 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| February 8, 2023 |
TRANSCRIPT Premier, Inc. Fiscal 2Q23 Earnings Call Tuesday, February 7, 2023 8:00 a.m. ET Exhibit 99.2 TRANSCRIPT Premier, Inc. Fiscal 2Q23 Earnings Call Tuesday, February 7, 2023 8:00 a.m. ET Premier Participants: Michael J. Alkire, President & CEO Craig McKasson, Chief Financial & Administrative Officer Angie McCabe, Vice President, Investor Relations Operator: Good morning, and welcome to Premier’s Fiscal 2023 Second Quarter Earnings Conference Call. [Operator Instructions] Please n |
|
| February 8, 2023 |
Fiscal 2023 Second-Quarter Earnings Conference Call /////// February 7, 2023 Exhibit 99. |
|
| February 8, 2023 |
Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2023 Second-Quarter Results Announces Cost-Savings Plan and Updates Fiscal-Year 2023 Guidance CHARLOTTE, N.C., February 7, 2023 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2023 second quarter ended December 31, 2022. The company also announced the impl |
|
| February 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36092 Premier |
|
| January 10, 2023 |
Premier Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023 Exhibit 99.2 Premier Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023 CHARLOTTE, NC, Jan. 3, 2023 – Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023. The company’s formal p |
|
| January 10, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2023 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 10, 2023 |
PINC / Premier Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0007-premierincclassa.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Premier Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 74051N102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designa |
|
| January 10, 2023 |
Forward-Looking Statements and Exhibit 99.1 EXHIBIT99.1 41st Annual J.P. Morgan Healthcare Conference Michael J. Alkire, President and CEO Craig McKasson, Chief Administrative and Financial Officer January 10, 2023 Forward-Looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such a |
|
| December 16, 2022 |
Exhibit 10.1 Execution Version AMENDED AND RESTATED CREDIT AGREEMENT Dated as of December 12, 2022 among PREMIER HEALTHCARE ALLIANCE, L.P., PREMIER SUPPLY CHAIN IMPROVEMENT, INC. and PREMIER HEALTHCARE SOLUTIONS, INC., as the Co-Borrowers, CERTAIN DOMESTIC SUBSIDIARIES OF THE CO-BORROWERS FROM TIME TO TIME PARTY HERETO, as Guarantors, WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent |
|
| December 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2022 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| December 2, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2022 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 2, 2022 |
Exhibit 99.3 Fiscal 2023 First-Quarter Earnings Conference Call /////// November 1, 2022 ? 2022. All rights reserved. | Premier Inc. | 1 Forward-looking Statements and Non-GAAP Financial Measures Forward-looking statements? Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to our ability to advance our lo |
|
| November 2, 2022 |
Premier, Inc. Reports Fiscal-Year 2023 First-Quarter Results Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2023 First-Quarter Results CHARLOTTE, N.C., November 1, 2022 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2023 first quarter ended September 30, 2022. ?Our fiscal 2023 first quarter results were consistent with our expectations, and we continued to make |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2022 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 2, 2022 |
Exhibit 99.2 01-Nov-2022 Premier, Inc. (PINC) Q1 2023 Earnings Call 1-877-FACTSET www.callstreet.com Total Pages: 16 Copyright ? 2001-2022 FactSet CallStreet, LLC CORPORATE PARTICIPANTS Angeline C. McCabe Vice President, Investor Relations, Premier, Inc. Michael J. Alkire President, Chief Executive Officer & Director, Premier, Inc. Craig S. McKasson Chief Financial Officer, Chief Administrative Of |
|
| November 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36092 Premie |
|
| October 19, 2022 |
EX-99.1 Exhibit 99.1 Premier, Inc.’s Subsidiary Contigo Health, LLC, Completes Asset Transaction for National Provider Contracts and Licenses to Cost Containment Technology New assets will support Contigo Health’s continued growth by expanding its nationwide footprint and enhancing the value proposition for direct-to-employer offerings October 13, 2022 04:20 PM Eastern Daylight Time CHARLOTTE, N.C |
|
| October 19, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 13, 2022 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 19, 2022 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 19, 2022 |
DEF 14A 1 d514164ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as |
|
| October 19, 2022 |
EX-99.1 Exhibit 99.1 2022 SUSTAINABILITY REPORT Making a Premier Impact TABLE OF CONTENTS LETTER FROM OUR PRESIDENT AND CEO 3 OVERVIEW 4 ABOUT US 5 OUR APPROACH TO SUSTAINABILITY 6 ABOUT THIS REPORT 9 2022 ESG HIGHLIGHTS 10 2022 AWARDS AND RECOGNITION 11 ETHICS AND COMPLIANCE 12 ETHICS AND COMPLIANCE 13 ENTERPRISE RISK MANAGEMENT AND BUSINESS CONTINUITY 14 CYBER RISK MANAGEMENT, DATA SECURITY AND |
|
| September 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 6, 2022 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| September 7, 2022 |
Exhibit 2.1 Execution Copy ASSET PURCHASE AGREEMENT by and among CONTIGO HEALTH, LLC, TRPN DIRECT PAY, INC., and DEVON HEALTH INC. Dated as of September 6, 2022 TABLE OF CONTENTS 1. SALE AND TRANSFER OF ASSETS TO BE SOLD, ASSUMED LIABILITIES AND CLOSING 1 1.1 Assets To Be Sold 2 1.2 Excluded Assets 2 1.3 Continuation Rights 3 1.4 Assumption of Assumed Liabilities 4 1.5 Excluded Liabilities 4 1.6 M |
|
| September 7, 2022 |
Exhibit 99.1 Premier, Inc.?s Subsidiary Contigo Health, LLC, to Acquire Contracts With 900,000 Providers and Licenses to Cost Containment Technology The acquisition will support Contigo Health?s continued growth by expanding its nationwide footprint and enhancing the value proposition for direct-to-employer offerings CHARLOTTE, N.C. (September 6, 2022) ? Premier, Inc. (NASDAQ: PINC) subsidiary Con |
|
| August 22, 2022 |
As filed with the Securities and Exchange Commission on August 22, 2022. As filed with the Securities and Exchange Commission on August 22, 2022. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PREMIER, INC. (Exact name of registrant as specified in its charter) Delaware 35-2477140 (State or other jurisdiction of incorporation or organization) (IRS Employer Id |
|
| August 22, 2022 |
Calculation of Filing Fee Table Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) PREMIER, INC. (Exact name of registrant as it appears in its charter) Table 1: Newly Registered Securities Security Type Security Class Title(1) Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Share(2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee(3) Equity Class A Common Stock, pa |
|
| August 17, 2022 |
AUGUST 16, 2022 / 12:00PM, PINC.OQ – Q4 2022 Premier Inc Earnings Call Exhibit 99.2 AUGUST 16, 2022 / 12:00PM, PINC.OQ ? Q4 2022 Premier Inc Earnings Call C O R P O R A T E P A R T I C I P A N T S Angeline C. McCabe Premier, Inc. ? VP of IR Craig S. McKasson Premier, Inc. ? Chief Administrative Officer, CFO, Senior VP & Treasurer Michael J. Alkire Premier, Inc. ? President, CEO & Director C O N F E R E N C E C A L L P A R T I C I P A N T S Albert J. William Rice Cr?d |
|
| August 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2022 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 17, 2022 |
Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2022 Fourth-Quarter and Full-Year Results Issues Fiscal-Year 2023 Guidance CHARLOTTE, N.C., August 16, 2022 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2022 fourth quarter and full year ended June 30, 2022 and issued its fiscal-year 2023 financial guid |
|
| August 17, 2022 |
Exhibit 99.3 Fiscal 2022 Fourth Quarter Earnings Conference Call /////// August 16, 2022 ? 2022. All rights reserved. | Premier Inc. | 1 Forward-looking Statements and Non-GAAP Financial Measures Forward-looking statements? Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to our ability to advance our lo |
|
| August 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Fiscal Year Ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OF 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission File Number 001-36092 Premier, Inc. (Exact name of r |
|
| August 16, 2022 |
Exhibit 21 SUBSIDIARIES OF PREMIER, INC. As of August 16, 2022 Name of Subsidiary State/Province of Incorporation Premier Healthcare Solutions, Inc. (1) Delaware Premier Services II, LLC (2) Delaware Premier Healthcare Alliance, L.P. (3) California Premier Supply Chain Improvement, Inc. (4) Delaware Premier Marketplace, LLC (4) Delaware Premier Supply Chain Holdings, LLC (4) Delaware NS3Health, LL |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2022 Premier, Inc. (Exact name of Registrant as specified in its charter) Delaware 001-36092 35-2477140 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| July 22, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 21, 2022 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 22, 2022 |
Stewardship Outreach /////// July 2022 Exhibit 99.1 Forward-looking Statements and Non-GAAP Financial Measures Forward-looking statements ? Statements made in this presentation that are not statements of historical or current facts, such as those related to expected growth opportunities in each of Premier?s business segments and the ability to realize such opportunities, strategic priorities to ad |
|
| May 23, 2022 |
CORRESP 1 filename1.htm May 20, 2022 U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services Attn: Amy Geddes and Lyn Shenk 100 F Street, NE Washington, DC 20549 Re: Premier, Inc. File No. 001-36092 Form 10-K for the Year Ended June 30, 2021 Filed August 17, 2021 Dear Ms. Geddes and Mr. Shenk: Set forth below is Premier, Inc.’s (the “Company”) response to |
|
| May 9, 2022 |
Fiscal 2022 Third Quarter Earnings Conference Call /////// May 3, 2022 Exhibit 99. |
|
| May 9, 2022 |
Premier, Inc. Reports Fiscal-Year 2022 Third-Quarter Results Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2022 Third-Quarter Results CHARLOTTE, N.C., May 3, 2022 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2022 third quarter ended March 31, 2022. ?As we expected, our fiscal 2022 third quarter results reflect the continued normalization of our Supply Chain |
|
| May 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 3, 2022 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 9, 2022 |
FISCAL 2022 THIRD QUARTER CONFERENCE CALL TRANSCRIPT May 3, 2022 / 08:00 AM EST Exhibit 99.2 FISCAL 2022 THIRD QUARTER CONFERENCE CALL TRANSCRIPT May 3, 2022 / 08:00 AM EST On May 3, 2022, Premier, Inc. hosted a conference call to discuss financial results for the fiscal 2022 third quarter, ended March 31, 2021. The following transcript is an interpretation of the statements made on the call. The actual conference call may have differed slightly. CORPORATE PARTICIPANTS Angeli |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36092 Premier, I |
|
| May 3, 2022 |
Amended and Restated Bylaws of Premier, Inc., effective as of January 20, 2022 AMENDED AND RESTATED BYLAWS OF PREMIER, INC. ARTICLE I STOCKHOLDERS Section 1. The annual meeting of the stockholders of Premier, Inc. (the "Corporation") for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on such date, and at such time and place, if any, within or without the State of Delaware as may be |
|
| April 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 26, 2022 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| April 26, 2022 |
Exhibit 10.1 SPECIAL RESTRICTED STOCK UNIT AGREEMENT Participant: [Participant Name] Grant Date: [Grant Date] Number of Award Shares: [Number of Awards Granted] Vesting Date: The third anniversary of the Grant Date (the ?Vesting Date?) This Special Restricted Stock Unit Agreement (the ?Award Agreement?) evidences the grant to the Participant by Premier, Inc. (the ?Company?) of the right to receive |
|
| February 10, 2022 |
PINC / Premier Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01697-premierincclassa.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Premier Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 74051N102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to design |
|
| February 2, 2022 |
FISCAL 2022 SECOND QUARTER CONFERENCE CALL TRANSCRIPT February 1, 2022 / 08:00 AM EST Exhibit 99.2 FISCAL 2022 SECOND QUARTER CONFERENCE CALL TRANSCRIPT February 1, 2022 / 08:00 AM EST On February 1, 2022, Premier, Inc. hosted a conference call to discuss financial results for the fiscal 2022 second quarter, ended December 31, 2021. The following transcript is an interpretation of the statements made on the call. The actual conference call may have differed slightly. CORPORATE PART |
|
| February 2, 2022 |
Fiscal 2022 Second Quarter Earnings Conference Call /////// February 1, 2022 Exhibit 99. |
|
| February 2, 2022 |
PINC / Premier Inc / MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* PREMIER, INC. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 74051N102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 2, 2022 |
Premier, Inc. Reports Fiscal Year 2022 Second Quarter Results Exhibit 99.1 Premier, Inc. Reports Fiscal Year 2022 Second Quarter Results CHARLOTTE, N.C., February 1, 2022 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2022 second quarter ended December 31, 2021. ?Our fiscal 2022 second quarter results reflect continued operational execution,? said Michael J. Alk |
|
| February 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 1, 2022 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| February 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36092 Premier |
|
| December 3, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 3, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| December 1, 2021 |
Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?), dated as of December 1, 2021, is by and among PREMIER HEALTHCARE ALLIANCE, L.P., a California limited partnership, PREMIER SUPPLY CHAIN IMPROVEMENT, INC., a Delaware corporation and PREMIER HEALTHCARE SOLUTIONS, INC., a Delaware corporation (each individually, a ?Borrower? and collectively |
|
| December 1, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 1, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| November 19, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 17, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) |
|
| November 19, 2021 |
2021 VIRTUAL INVESTOR DAY TRANSCRIPT November 17, 2021 Exhibit 99.2 2021 VIRTUAL INVESTOR DAY TRANSCRIPT November 17, 2021 On November 17, 2021, Premier, Inc. hosted a Virtual Investor Day. The following transcript is an interpretation of the statements made during the presentation. The actual presentation may have differed slightly. CORPORATE PARTICIPANTS Andy Brailo Premier, Inc. ? Chief Customer Officer Angeline C. McCabe Premier, Inc. ? VP of IR M |
|
| November 19, 2021 |
Exhibit 99.1 N O VE MB E R 17, 2021 ? 2021. All rights reserved. | Premier Inc. 1 Forward-looking statements ? Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as, but not limited to, those related to leveraging technology and positioning for sustainable, long-term growth, strategies to drive growth, future financial pos |
|
| November 17, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 17, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| November 17, 2021 |
Premier, Inc. to Host Virtual Investor Day on November 17, 2021 Exhibit 99.2 Premier, Inc. to Host Virtual Investor Day on November 17, 2021 CHARLOTTE, N.C., November 2, 2021 - Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that the company will host its 2021 Virtual Investor Day on Wednesday, November 17, 2021, from approximately 9 a.m. to 11 a.m. ET. The event will feature presentations and a Q&A ses |
|
| November 17, 2021 |
Exhibit 99.1 N O VE MB E R 17, 2021 ? 2021. All rights reserved. | Premier Inc. 1 Forward-looking statements ? Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as, but not limited to, those related to leveraging technology and positioning for sustainable, long-term growth, strategies to drive growth, future financial pos |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 2, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| November 4, 2021 |
Premier, Inc. Reports Fiscal-Year 2022 First-Quarter Results Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2022 First-Quarter Results CHARLOTTE, N.C., November 2, 2021 - Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year 2022 first quarter ended September 30, 2021. ?We entered fiscal 2022 with strong momentum and are pleased with our fiscal 2022 first quarter results as we continue to make progress in advancing our longer-ter |
|
| November 4, 2021 |
Fiscal 2022 First Quarter Earnings Conference Call /////// November 2, 2021 Exhibit 99. |
|
| November 4, 2021 |
FISCAL 2022 FIRST QUARTER CONFERENCE CALL TRANSCRIPT November 2, 2021 / 08:00 AM EDT Exhibit 99.2 FISCAL 2022 FIRST QUARTER CONFERENCE CALL TRANSCRIPT November 2, 2021 / 08:00 AM EDT On November 2, 2021, Premier, Inc. hosted a conference call to discuss financial results for the fiscal 2022 first quarter, ended September 30, 2021. The following transcript is an interpretation of the statements made on the call. The actual conference call may have differed slightly. CORPORATE PARTI |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36092 Premie |
|
| October 21, 2021 |
DEFR14A 1 d231146ddefr14a.htm DEFR14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as |
|
| October 21, 2021 |
Exhibit 99.1 Making a Premier Impact 2021 Sustainability Report Table of Contents Letter From Our President and CEO 3 Making a Premier Impact 5 Our Business Segments 5 Our Brands 6 Awards, Recognition and Associations 8 Corporate Professional Associations 8 About This Report 9 Governance, Ethics and Responsible Business Practices 10 Supply Chain Management 34 Environmental, Social and Governance O |
|
| October 21, 2021 |
Amended and Restated Bylaws of Premier, Inc., effective as of October 21, 2021. EX-3.2 2 d246516dex32.htm EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF PREMIER, INC. ARTICLE I STOCKHOLDERS Section 1. The annual meeting of the stockholders of Premier, Inc. (the “Corporation”) for the purpose of electing directors and for the transaction of such other business as may properly be brought before the meeting shall be held on such date, and at such time and place, if any, withi |
|
| October 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 20, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| October 20, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defi |
|
| October 20, 2021 | ||
| September 7, 2021 |
Exhibit 10.3 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (?Agreement?) effective as of September 1, 2021 (the ?Effective Date?), is made by and between Premier, Inc., a Delaware corporation (?Company?), and William Mayer (?Consultant?). Company and Consultant are referred to collectively as the ?Parties? and each individually as a ?Party?. WHEREAS, Consultant is a former director of Company, an |
|
| September 7, 2021 |
Exhibit 10.4 RESTRICTED STOCK UNIT AGREEMENT FOR CONSULTANTS Participant: [ ] (the ?Participant?) Grant Date: [ ] (the ?Grant Date?) Number of Award Shares: [ ] Vesting Date: Shall vest in full on the first anniversary of the Grant Date (the ?Vesting Date?). 1. Grant of Restricted Stock Units. This restricted stock unit award (?Award?) is granted pursuant to the Amended and Restated Premier Inc. 2 |
|
| September 7, 2021 |
Exhibit 10.2 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (?Agreement?) effective as of September 1, 2021 (the ?Effective Date?), is made by and between Premier, Inc., a Delaware corporation (?Company?), and David Langstaff (?Consultant?). Company and Consultant are referred to collectively as the ?Parties? and each individually as a ?Party?. WHEREAS, Consultant is a former director of Company, |
|
| September 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 31, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| September 7, 2021 |
Exhibit 10.1 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (?Agreement?) effective as of September 1, 2021 (the ?Effective Date?), is made by and between Premier, Inc., a Delaware corporation (?Company?), and Stephen D?Arcy (?Consultant?). Company and Consultant are referred to collectively as the ?Parties? and each individually as a ?Party?. WHEREAS, Consultant is a former director of Company, a |
|
| August 18, 2021 |
Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2021 Fourth-Quarter and Full-Year Results and Issues Fiscal-Year 2022 Guidance CHARLOTTE, N.C., August 17, 2021?Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal-year 2021 fourth quarter and full year ended June 30, 2021 and issued its fiscal-year 2022 financial guidance. ?We are pleased with our fourth quarter performance w |
|
| August 18, 2021 |
FISCAL 2021 FOURTH QUARTER CONFERENCE CALL TRANSCRIPT August 17, 2021 / 08:00 AM EDT Exhibit 99.2 FISCAL 2021 FOURTH QUARTER CONFERENCE CALL TRANSCRIPT August 17, 2021 / 08:00 AM EDT On August 17, 2021, Premier, Inc. hosted a conference call to discuss financial results for the fiscal 2021 fourth quarter, ended June 30, 2021. The following transcript is an interpretation of the statements made on the call. The actual conference call may have differed slightly. CORPORATE PARTICIPAN |
|
| August 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 17, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| August 18, 2021 |
Fiscal 2021 Fourth Quarter Earnings Conference Call August 17, 2021 Exhibit 99.3 Forward-looking Statements and Non-GAAP Financial Measures Forward-looking statements ? Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to the timing and continuing impact of COVID-19, the ability to execute our strategy in |
|
| August 17, 2021 |
EX-21 2 ex21-pincxfy210630.htm EX-21 Exhibit 21 SUBSIDIARIES OF PREMIER, INC. As of August 17, 2021 Name of Subsidiary State/Province of Incorporation Premier Services, LLC (1) Delaware Premier Services II, LLC (1) Delaware Premier Healthcare Alliance, L.P. (2) California Premier Supply Chain Improvement, Inc. (3) Delaware Premier Healthcare Solutions, Inc. (3) Delaware Premier Marketplace, LLC (3 |
|
| August 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Fiscal Year Ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OF 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transition Period From To Commission File Number 001-36092 Premier, Inc. (Exact name of r |
|
| August 5, 2021 |
Exhibit 10.1 SPECIAL RESTRICTED STOCK UNIT AGREEMENT Participant: [Participant Name] Grant Date: [Grant Date] Number of Award Shares: [Number of Awards Granted] Vesting Date: The third anniversary of the Grant Date (the ?Vesting Date?) This Special Restricted Stock Unit Agreement (the ?Award Agreement?) evidences the grant to the Participant by Premier, Inc. (the ?Company?) of the right to receive |
|
| August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 4, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| July 19, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 19, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| July 19, 2021 |
Premier, Inc. Company Overview July 2021 Exhibit 99.1 Forward-looking Statements and Non-GAAP Financial Measures Forward-looking statements ? Statements made in this presentation that are not statements of historical or current facts, such as those related to expected growth opportunities in each of Premier?s business segments and the ability to realize such opportunities, strategic priorities to |
|
| May 5, 2021 |
FISCAL 2021 THIRD QUARTER CONFERENCE CALL TRANSCRIPT May 4, 2021 / 08:00 AM EDT Exhibit 99.2 FISCAL 2021 THIRD QUARTER CONFERENCE CALL TRANSCRIPT May 4, 2021 / 08:00 AM EDT On May 4, 2021, Premier, Inc. hosted a conference call to discuss financial results for the fiscal 2021 third quarter, ended March 31, 2021. The following transcript is an interpretation of the statements made on the call. The actual conference call may have differed slightly. CORPORATE PARTICIPANTS Angeli |
|
| May 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 4, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| May 5, 2021 |
Third-Quarter Fiscal 2021 Financial Results and Update May 4, 2021 Exhibit 99.3 Forward-looking statements and non-GAAP financial measures Forward-looking statements ? Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to the timing and continuing impact of COVID-19, anticipated changes under the current C |
|
| May 5, 2021 |
Premier, Inc. Reports Fiscal-Year 2021 Third-Quarter Results and Raises Fiscal Year 2021 Guidance Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2021 Third-Quarter Results and Raises Fiscal Year 2021 Guidance CHARLOTTE, N.C., May 4, 2021 - Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year (FY) 2021 third quarter ended March 31, 2021 and raised its fiscal 2021 financial guidance. ?I am excited to take the reins as Premier?s new CEO and am pleased with our fiscal |
|
| May 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36092 Premier, I |
|
| March 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 1, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| February 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* PREMIER, INC. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 74051N102 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: Premier Inc. Class A Title of Class of Securities: Common Stock CUSIP Number: 74051N102 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
|
| February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 2, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| February 4, 2021 |
FISCAL 2021 SECOND QUARTER CONFERENCE CALL TRANSCRIPT February 2, 2021 / 08:00 AM EST EX-99.2 Exhibit 99.2 FISCAL 2021 SECOND QUARTER CONFERENCE CALL TRANSCRIPT February 2, 2021 / 08:00 AM EST On February 2, 2021, Premier, Inc. hosted a conference call to discuss financial results for the fiscal 2021 second quarter, ended December 31, 2020. The following transcript is an interpretation of the statements made on the call. The actual conference call may have differed slightly. CORPOR |
|
| February 4, 2021 |
Premier, Inc. Reports Fiscal-Year 2021 Second-Quarter Results Company Initiates Fiscal 2021 Guidance EX-99.1 Exhibit 99.1 Premier, Inc. Reports Fiscal-Year 2021 Second-Quarter Results Company Initiates Fiscal 2021 Guidance CHARLOTTE, N.C., Feb. 2, 2021 - Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year (FY) 2021 second quarter ended December 31, 2020 and announced its fiscal 2021 financial guidance. All results presented in this press release reflect continuing op |
|
| February 4, 2021 |
EX-99.3 Second-Quarter Fiscal 2021 Financial Results and Update February 2, 2021 Exhibit 99.3 Forward-looking statements and non-GAAP financial measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to the timing and continuing impact of COVID-19, anticipated changes under |
|
| February 2, 2021 |
as of January 1, 2021 by and between Lindsay Powers and Premier Healthcare Solutions, Inc. EX-10.1 2 ex101-pincxfy21x1231.htm EXHIBIT 10.1 Exhibit 10.1 EXECUTIVE EMPLOYMENT AND RESTRICTIVE COVENANT AGREEMENT I, LINDSAY POWERS, hereby agree to be employed by Premier Healthcare Solutions, Inc. (the “Company”) and the Company hereby agrees to employ me, subject to the following terms and conditions (the “Agreement”). 1.EMPLOYMENT 1.1Job Duties. I agree to devote my full professional time, |
|
| February 2, 2021 |
EX-10.2 Exhibit 10.2 SENIOR EXECUTIVE EMPLOYMENT AGREEMENT THIS SENIOR EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into by and among Michael J. Alkire (“Executive”) and Premier Healthcare Solutions, Inc., a Delaware corporation with its principal place of business in Charlotte, North Carolina (“Premier” or the “Company”) (each and collectively defined and referred to herei |
|
| February 2, 2021 |
EX-99.1 Exhibit 99.1 Premier Inc. President Michael J. Alkire to Succeed Susan DeVore as Chief Executive Officer DeVore to Retire on June 30, 2021; Alkire to Assume President and CEO Role Effective May 1, 2021 CHARLOTTE, N.C. – February 2, 2021 – Premier Inc. (NASDAQ: PINC) today announced that after nearly 18 years of distinguished service, Susan DeVore is retiring as the company’s chief executiv |
|
| February 2, 2021 |
EX-10.1 Exhibit 10.1 FIRST AMENDMENT TO SENIOR EXECUTIVE EMPLOYMENT AGREEMENT This First Amendment to Senior Executive Employment Agreement (the “Amendment”) is entered into effective as of February 1, 2021 (the “Amendment Effective Date”) by and between Premier Healthcare Solutions, Inc. (“Premier” or the “Company”) and Susan D. Devore (“Executive”). Premier and Executive shall be referred to her |
|
| February 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 1, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| February 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36092 Premier |
|
| January 12, 2021 |
EX-99.2 Exhibit 99.2 Premier Inc. to Participate in the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 12, 2021 CHARLOTTE, NC, Jan. 6, 2021 – Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a presentation and fireside chat at the 39th Annual J.P. Morgan Virtual Healthcare Co |
|
| January 12, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 12, 2021 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| January 12, 2021 |
EX-99.1 J.P. Morgan 39th Annual Healthcare Conference Susan DeVore Chief Executive Officer January 12, 2021 Exhibit 99.1 Forward-looking Statements and Non-GAAP Financial Measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to expected growth opportunities in each of Pre |
|
| December 7, 2020 |
Submission of Matters to a Vote of Security Holders - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 4, 2020 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| November 4, 2020 |
EX-99.3 First-Quarter Fiscal 2021 Financial Results and Update November 2, 2020 Exhibit 99.3 Forward-looking statements and non-GAAP financial measures Forward-looking statements – Statements made in this presentation and the accompanying webcast that are not statements of historical or current facts, such as those related to the expected financial and operational impacts and challenges of the COV |
|
| November 4, 2020 |
FISCAL 2021 FIRST QUARTER CONFERENCE CALL TRANSCRIPT November 2, 2020 / 05:00 PM EST EX-99.2 Exhibit 99.2 FISCAL 2021 FIRST QUARTER CONFERENCE CALL TRANSCRIPT November 2, 2020 / 05:00 PM EST On November 2, 2020, Premier, Inc. hosted a conference call to discuss financial results for the fiscal 2021 first quarter, ended September 30, 2020. The following transcript is an interpretation of the statements made on the call. The actual conference call may have differed slightly. CORPORA |
|
| November 4, 2020 |
Premier, Inc. Reports Fiscal 2021 First-Quarter Results EX-99.1 Exhibit 99.1 Premier, Inc. Reports Fiscal 2021 First-Quarter Results CHARLOTTE, N.C., Nov. 2, 2020 - Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year (FY) 2021 first quarter ended September 30, 2020. All results presented in this press release reflect continuing operations following completion of the sale and exit of the Specialty Pharmacy business on June |
|
| November 4, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 2, 2020 Premier, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-36092 35-2477140 (State or Other Jurisdiction of Incorporation) (Commission File Num |
